Foghorn Therapeutics

100 Binney Street
Suite 610
United States

Tel: 617-586-3100


Show jobs for this employer

About Foghorn Therapeutics

A Flagship Pioneering company, Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order.

By manipulating this system with our unique Gene Traffic ControlTM Platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease.

With the Gene Traffic ControlTM Platform, Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.

10 articles with Foghorn Therapeutics